DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹423 Cr | ₹427 Cr | ₹443 Cr | ₹415 Cr | ₹394 Cr |
What is the latest Contingent Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹423 Cr |
| Mar2024 | ₹427 Cr |
| Mar2023 | ₹443 Cr |
| Mar2022 | ₹415 Cr |
| Mar2021 | ₹394 Cr |
How is Contingent Liabilities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹423 Cr | -0.91 | |
| Mar2024 | ₹427 Cr | -3.52 | |
| Mar2023 | ₹443 Cr | 6.70 | |
| Mar2022 | ₹415 Cr | 5.24 | |
| Mar2021 | ₹394 Cr | - | |
Compare Contingent Liabilities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,540.9 Cr | -3.3% | -4.1% | -39.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -3.3% |
-4.1% |
-39.4% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses